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hardly imagine today’s electronics industry, with its powerful, visually 
oriented design and automation tools, without having first established 
standard notations for circuit diagrams. Such was not the case in biol-
ogy2. Despite the visual nature of much of the information exchange, 
the field was permeated with ad hoc graphical notations having little 
in common between different researchers, publications, textbooks 
and software tools. No standard visual language existed for describing 
biochemical interaction networks, inter- and intracellular signaling 
gene regulation—concepts at the core of much of today’s research in 
molecular, systems and synthetic biology. The closest to a standard is 
the notation long used in many metabolic and signaling pathway maps, 
but in reality, even that lacks uniformity between sources and suffers 
from undesirable ambiguities (Fig. 1). Moreover, the existing tenta-
tive representations, however well crafted, were ambiguous, and only 
suitable for specific needs, such as representing metabolic networks or 
signaling pathways or gene regulation.
The molecular biology era, and more recently the rise of genomics 
and other high-throughput technologies, have brought a staggering 
increase in data to be interpreted. It also favored the routine use 
of software to help formulate hypotheses, design experiments and 
interpret results. As a group of biochemists, modelers and computer 
scientists working in systems biology, we believe establishing stan-
dard graphical notations is an important step toward more efficient 
and accurate transmission of biological knowledge among our dif-
ferent communities. Toward this goal, we initiated the SBGN project 
in 2005, with the aim of developing and standardizing a systematic 
and unambiguous graphical notation for applications in molecular 
and systems biology.
Historical antecedents
Graphical representation of biochemical and cellular processes has 
been used in biochemical textbooks as far back as sixty years ago3, 
reaching an apex in the wall charts hand drawn by Nicholson4 and 
Michal5. Those graphs describe the processes that transform a set of 
inputs into a set of outputs, in effect being process, or state transition, 
diagrams. This style was emulated in the first database systems that 
depicted metabolic networks, including EMP6, EcoCyc7 and KEGG8. 
More notations have been ‘defined’ by virtue of their implementation 
in specialized software tools such as pathway and network design-
ers (e.g., NetBuilder9, Patika10, JDesigner11, CellDesigner12). Those 
Circuit diagrams and Unified Modeling Language 
diagrams are just two examples of standard visual 
languages that help accelerate work by promoting 
regularity, removing ambiguity and enabling software 
tool support for communication of complex information. 
Ironically, despite having one of the highest ratios of 
graphical to textual information, biology still lacks 
standard graphical notations. The recent deluge of 
biological knowledge makes addressing this deficit 
a pressing concern. Toward this goal, we present 
the Systems Biology Graphical Notation (SBGN), 
a visual language developed by a community of 
biochemists, modelers and computer scientists. SBGN 
consists of three complementary languages: process 
diagram, entity relationship diagram and activity flow 
diagram. Together they enable scientists to represent 
networks of biochemical interactions in a standard, 
unambiguous way. We believe that SBGN will foster 
efficient and accurate representation, visualization, 
storage, exchange and reuse of information on all 
kinds of biological knowledge, from gene regulation, to 
metabolism, to cellular signaling.
“Un bon croquis vaut mieux qu’un long discours” (“A good sketch is 
better than a long speech”), said Napoleon Bonaparte. This claim is 
nowhere as true as for technical illustrations. Diagrams naturally engage 
innate cognitive faculties1 that humans have possessed since before the 
time of our cave-drawing ancestors. Little wonder that we find ourselves 
turning to them in every field of endeavor. Just as with written human 
languages, communication involving diagrams requires that authors 
and readers agree on symbols, the rules for arranging them and the 
interpretation of the results. The establishment and widespread use 
of standard notations have permitted many fields to thrive. One can 
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•  support representation of diverse common biological objects, their 
properties and their interactions;
•  keep the number of symbols and syntax to a minimum to help 
comprehension and learning by humans;
•  be visually consistent and concise, using discriminable symbols;
•  support modularity to help cope with diagram size and complexity;
•  support the automated generation of diagrams by software starting 
from mathematical models.
Many of the design principles above resonate with research on 
visual languages25,26 and studies aimed at understanding end-user 
needs in pathway visualization27, although we derived them from 
our collective hands-on experiences with developing notations and 
software. In addition to these principles, we also sought to avoid 
many problems (Table 1) that affect some existing notations.
SBGN aims to specify the connectivity of the graphs and the types 
of the nodes and edges, but not the precise layout of the graphs. 
The semantics of an SBGN diagram does not depend on the relative 
position of the symbols. Furthermore, it does not depend on colors, 
patterns, shades, shapes and thickness of edges (Fig. 2). Similarly, 
the labels of symbols are not regulated and are only required to be 
unique within a map.
Finally, it was clear at the outset that it would be impossible to 
design a perfect and complete language from the beginning. Apart 
from the prescience this would require, it also would likely require 
a vast language that most newcomers would shun as being too 
complex. Thus, the SBGN community decided to stratify language 
development into levels. A level in SBGN represents a usable set of 
functionalities that the user community agrees is sufficient for a 
reasonable set of tasks and goals. Capabilities and features that can-
not be agreed upon and are judged insufficiently critical to require 
inclusion in a given level are postponed to a higher level. In this way, 
SBGN development is envisioned to proceed in stages, with each 
higher SBGN level adding richness compared to the levels below 
it, while maintaining compatibility whenever possible. Furthermor 
only the actual usage of SBGN languages will tell us how well they 
work for the diverse communities involved, and this experience will 
certainly shape the evolution of the notation.
graphical notations were not standardized, and their understanding 
relied mainly on relating examples with one’s preexisting knowledge 
of biochemical processes. Although the classical graphs adequately 
conveyed information about biochemistry, other types of diagrams 
were needed to represent signaling pathways, and incomplete or indi-
rect information, as coming from molecular biology or genomics. 
Those conventions effectively mimicked the empirical notations used 
by biologists, describing either the relationships between elements13,14 
or the flow of activity or influence15–17. Lists of standard glyphs (Box 
1) to represent identified concepts were then provided. The efforts to 
create rigidly defined schema were pioneered by Kurt Kohn with his 
Molecular Interaction Maps (MIM), which defined not only a set of 
symbols but also a syntax to describe interactions and relationships 
of molecules18,19. The MIM notation influenced other proposals14. 
Several proposals followed to describe process diagrams, not only with 
standard symbols but also defined grammars20–23.
The SBGN project
Despite the popularity of some of the efforts mentioned above, none 
of the notations has acquired the status of a community standard. This 
can be attributed partly to the fact that the efforts only went as far as 
to propose notations, or implement them in software. Several of us 
have been involved in the development of the Systems Biology Markup 
Language (SBML)24, from which we learned that establishing a standard 
is extremely difficult without an explicit, concerted, effort to engage a 
community and build a consensus among participants. We organized 
the SBGN project with this lesson in mind.
For SBGN to be successful, it must satisfy a majority of technical 
and practical needs and be embraced by a diverse community of 
biologists, biochemists, bioinformaticians, geneticists, theoreticians 
and software engineers. Early in the project’s history, we established 
the following overarching principles to help steer SBGN toward those 
aims, ranked by rough hierarchical order of precedence.
The notation should
•  be free of intellectual property restrictions to allow free use by the 
community;
•  be syntactically and semantically consistent and unambiguous;
a b c
Figure 1  Inconsistency and ambiguity of current nonstandardized notations. (a) Eight different meanings associated with the same symbol in a chart 
describing the role of cyclin in cell regulations (http://www.abcam.com/ps/pdf/nuclearsignal/cell_cycle.pdf). (b) Nine different symbols found in the literature 
to represent the same meaning. (c) Five different representations of the MAP kinase cascade found in the scientific literature, depicting progressive levels of 
biological and biochemical knowledge. From left to right: relations30, directionality of influence31, directionality of effect32, biochemical effect33, chemical 
reactions34. In the last diagram, different instances of an identical arrowhead style represent catalysis, production and inhibition.
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SBGN process diagram
A process diagram represents all the molecular processes and inter-
actions taking place between biochemical entities, and their results. 
This type of diagram depicts how entities transition from one form 
to another as a result of different influences; thus, it portrays the 
temporal qualities of molecular events occurring in biochemical 
reactions. In this way, the approach underlying process diagrams 
is the same as in the familiar textbook drawings of metabolic path-
ways. The main drawback of process diagrams is that a given entity 
must appear multiple times in the same diagram if it exists under 
several states; therefore, the notation is sensitive to the combinato-
rial explosion of possible entities and reactions, as is often the case 
in signaling pathways.
The SBGN process diagram level 1 specification defines six 
major classes of glyphs: entity pool nodes, process nodes, con-
tainer nodes, reference nodes, connecting arcs and logical operators 
(Supplementary Note 1). In Figure 3a, we show a complete example 
of an SBGN process diagram. The number of symbols in level 1 of 
the SBGN process diagram notation has been purposefully limited so 
that they could be easily memorized. The notation may be enriched 
(perhaps using subclasses of symbols) in higher levels of SBGN.
Table 3 lists software projects that are already developing support 
for SBGN process diagram level 1 (see also Supplementary Note 2). 
Some of these rely on manual design of the pathways, whereas others, 
such as Arcadia, automatically generate SBGN PD from SBML mod-
els that have been annotated with terms from the Systems Biology 
Ontology29. The encoding of SBGN diagrams using computer-read-
able formats, a crucial step toward exchange and reuse of SBGN 
The three languages of SBGN
Molecular entities possess many properties that affect their 
interactions with other entities. Attempting to represent all the pos-
sible reactions and interactions in the same diagram is often futile, 
usually resulting in an incomprehensible jumble. The different styles 
of notations described above were attempts to control this com-
plexity by presenting only what was needed in a specific context, 
or what was available through specific views of the system14. Each 
view focuses on only a portion of the semantics of the overall sys-
tem, trading off diagram comprehensibility against completeness of 
biological knowledge.
SBGN follows this strategy and defines three orthogonal and com-
plementary types of diagrams that can be seen as three alternative 
projections of the underlying more complex biological information. 
The process diagram draws its inspiration from process-style nota-
tions, borrowing ideas from the work of CellDesigner28 and EPE22. By 
contrast, the entity relationship diagram is based to a large extent on 
Kohn’s MIM notation18,19. The SBGN activity flow diagram depicts 
only the cascade of activity, thus making the notation similar to 
the reduced representations often used in the current literature to 
describe signaling pathways and gene regulatory networks. In Figure 
2, we illustrate the three views applied to a very simple example. The 
characteristics of the SBGN languages are summarized in Table 2.
The idea of having three diagram types naturally begs the question 
of whether they could be merged into one, at least in paper form. 
The answer is no, for at least two reasons. First, a single diagram 
type would bring us back to the problem of dealing with unreason-
able numbers of interactions as described above. Second, each SBGN 
language reflects fundamental differences in the underlying formal 
description of the phenomena. The meanings are so different that 
merging diagram types would compromise their representational 
robustness.
Having multiple visual languages is not uncommon in engineer-
ing (consider, for example, block diagrams and circuit diagrams in 
electronics, UML class, state sequence and deployment diagrams in 
software engineering), and this supports the idea that having three 
sublanguages in SBGN will be manageable in practice. In SBGN, the 
sharing of symbols representing identical concepts further reduces 
the differences between the three languages to differences in syntax 
and semantics. We believe that this, combined with careful design, will 
mitigate some of the difficulties of learning SBGN. However, it is to be 
noted that the clean orthogonality of the languages makes their over-
lap very limited, mostly to modulatory arcs, and node decorations.
Table 1  Features of ad hoc graphical notations, and the problems they create
Feature Problem(s)
Different line thicknesses distinguish different types of processes or elements 
Dotted or dashed line styles distinguish different types of processes or elements
1. rescaling a diagram can make line thicknesses and styles impossible to discern 
2. Photocopying or faxing a diagram can cause differences in line thicknesses and 
styles to disappear 
3. Differences in line thickness and style are difficult to make consistent in dia-
grams drawn by hand
Different colors distinguish different types of processes or elements 1. Photocopying or faxing a diagram will cause color differences to be indistin-
guishable 
2. color characteristics are difficult to achieve and keep consistent when drawing 
diagrams by hand
Identical line terminators (e.g., a single arrow) indicate different effects or 
processes depending on context
1. Greater ambiguity is introduced into a diagram 
2. Interpreting a diagram requires more thought on the part of the reader 
3. Automated verification of diagrams is more difficult due to lack of distinction 
between different processes or elements
Ad hoc symbols introduced at will by author Interpreting a diagram requires the reader to search for additional information 
explaining the meaning of the symbols
Box 1  Glossary
sBGN diagrams are a specific set of graphs and thus make 
use of concepts from graph theory. the following list defines 
the terms used most often. We are aware of the unavoidable 
circularity of such definitions.
•  Arc. A directed edge, that is, an edge that is not symmetrical 
in shape.
•  Edge. A line joining two nodes.
•  Glyph. A symbol that conveys information nonverbally.
•  Graph. A set of nodes connected with edges.
•  Node. A point that terminates a line or curve or comprises the 
intersection of two or more lines or curves.
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support this by allowing the interaction with the ligand to modulate the 
assignment of the variable representing the activity. The trade-off is that 
the temporal course is difficult to follow in entity relationships, because 
the sequence of events is not explicitly described (Fig. 2a,b).
The specification of SBGN entity relationship diagram level 1 defines 
three major classes of glyphs: entity nodes, statements and influences 
(logical operators are entity nodes). We summarize the symbols and the 
rules for their assembly (Supplementary Note 3). In Fig. 3b, we show a 
complete example of an SBGN entity relationship diagram.
SBGN activity flow diagram
A strategy often used for coping with biochemical network complexity 
or with incomplete or indirect knowledge is to selectively ignore the 
biochemical details of processes, instead representing the influences 
between entities directly. SBGN’s activity flow diagrams permit modu-
latory arcs to directly link different activities, rather than entities and 
processes or relationships as described previously. Instead of displaying 
the details of biochemical reactions with process nodes and connecting 
arcs, the activity flow diagrams show only influences such as ‘stimula-
tion’ and ‘inhibition’ between the activities displayed by the molecular 
entities (Fig. 2c). For example, a signal ‘stimulates’ the activity of a 
receptor, and this activity in turn ‘stimulates’ the activity of an intracel-
lular transducing protein (note that activity flow retains the sequential 
chains of influences). Because most signaling pathway diagrams in the 
current literature are essentially activity flow diagrams, we expect many 
biologists will find this type of diagram familiar.
diagrams, is currently supported in different formats such as SBML, 
GML and GraphML by different tools, and a general XML-based 
exchange format for SBGN is currently under discussion.
SBGN entity relationship diagram
The SBGN notation for entity relationships puts the emphasis on the 
influences that entities have upon each other’s transformations rather 
than the transformations themselves. One can imagine that each of the 
relationships represents a specific conclusion of a scientific experiment 
or article. Their addition on a map represents the knowledge we have 
of the effects the entities have upon each other. Contrary to the process 
diagrams, where the different processes affect each other, the relation-
ships are independent, and this independence is the key to avoiding the 
combinatorial explosion inherent to process diagrams. Unlike in pro-
cess diagrams, a given entity may appear only once. Readers can better 
grasp at first sight all the possible influences and interactions affecting 
an entity, without having to explore the whole diagram to discover the 
different states an entity may be in, or to trace all the edges to find the 
relevant process nodes.
The relationship symbols in entity relationship diagrams support 
the representation of interactions and state variable assignments, 
thus allowing the notation to describe certain processes that cannot 
be expressed in process diagrams, such as allosteric modulation. In 
process diagrams, one can represent the formation of a ligand-receptor 
complex, but it is not possible to state that the complex is more active 
than the receptor alone without additional markup; entity relationships 
a b c Figure 2  simple example of protein 
phosphorylation catalyzed by an enzyme and 
modulated by an inhibitor. the semantics of 
an sBGN diagram does not depend on the 
relative position of the symbols, or on colors, 
patterns, shades, shapes and thickness of 
edges. therefore, the upper and lower diagrams 
are identical as far as sBGN is concerned, and 
have to be interpreted exactly the same way. 
(a) Process diagrams, explicitly displaying 
the four forms of ErK, phosphorylated and 
nonphosphorylated on the tyrosine and 
the threonine, as well as the processes of 
phosphorylation by MEK and the inhibition of 
MEK by complexation with u0126. Note that 
the inhibition in this diagram emerges from 
the sequestration of MEK and is not explicitly 
represented. the phosphorylation sites are 
represented by variables, which in this example 
are labeled simply as ‘Y’ and ’t’ (but in general 
could be anything desired by the diagram 
author), shown adorning the main symbols for 
ErK. (b) Entity relationship diagrams, showing 
ErK and the assignment of its phosphorylations 
(at the tyrosine and threonine residues), as 
well as the relationships between those and 
MEK and u0126. Note that ErK appears only 
once in this diagram; the different possible 
states are not explicitly depicted. (c) Activity 
flow diagrams depicting the activation of ErK 
by MEK and the inhibition of MEK by u0126. 
In this notation, only the relevant activities of 
u0126, MEK and ErK are represented, as well 
as abstract representations of the influences 
of activities upon each other, whereas the 
biochemical details are omitted.
PE rs PE ct IvE
©
20
09
 N
at
ur
e 
A
m
er
ic
a,
 
In
c.
 
 
A
ll 
rig
ht
s 
re
se
rv
ed
.
nature biotechnology   volume 27   number 8   august 2009 739
by joining the SBGN discussion list (sbgn-discuss@sbgn.org). Face-
to-face meetings of the SBGN community, generally held as satellite 
workshops of larger conferences, are announced on the website as 
well as the mailing list.
Standardizing a notation for depicting networks of biochemical 
interactions has so far remained an elusive goal, despite numerous but 
isolated efforts in that direction. Only with such a standardized notation 
will biologists, modelers and computer scientists be able to exchange 
accurate descriptions of complex systems—a task that continues to 
grow more demanding as our collective knowledge expands. SBGN 
blends many influences from past efforts, and also introduces many new 
ideas designed to overcome limitations of other notations.
Using a community-based approach involving many interested 
groups and individuals (including some who have been involved in 
previous efforts), we have developed and released the first version 
of the three languages of the SBGN, the process diagram, the entity 
relationship diagram and the activity flow diagram.
Future levels of the three languages should address major chal-
lenges currently faced by the systems biology community, as the field 
matures and diversifies. To cite but a few examples, the representation 
of spatial structures and spatial events, of composed and modular 
models, and of dynamic creation or destruction of compartments 
remains unchartered territory.
By ignoring processes and entity states, the number of nodes in an 
activity flow diagram is greatly reduced compared to an equivalent pro-
cess diagram (Fig. 2a,c). Activity flow diagrams are also especially con-
venient for representing the effects of perturbations, whether genetic or 
environmental, because the complete mechanisms of the perturbations 
may not be known, or are irrelevant to the goals of a given study. The 
drawback is that activity flow diagrams may contain a high level of 
ambiguity. For instance, the biochemical basis of a positive or negative 
influence in a given system is left undefined. For this reason, this type 
of SBGN diagram should not exist alone; it should be associated, when 
possible, with detailed entity relationship and process diagrams, and 
used only for viewing purposes. We expect it will often be possible to 
generate activity flow diagrams mechanically from process diagrams 
and entity relationships, and have already performed preliminary work 
in that direction.
The SBGN activity flow diagram level 1 specification defines four 
major classes of glyphs: activity nodes, container nodes, modulating 
arcs and logical operators (Supplementary Note 4). Figure 3c shows a 
complete example of an SBGN activity flow diagram.
Participation and future prospects
The SBGN website (http://sbgn.org/) is a portal for all things related 
to SBGN. Interested persons can get involved in SBGN discussions 
Table 2  Comparison between the three languages of SBGN
Process diagram Entity relationship diagram Activity flow diagram
Purpose represent processes that convert physical 
entities into other entities, change their 
states or change their location
represent the interactions between entities 
and the rules that control them
represent the influence of biological activities 
on each other
Building block Different states of physical entities are repre-
sented separately
Physical entities are represented only once Different activities of physical entities are rep-
resented separately
Ambiguity Unambiguous transcription into biochemical 
events
Unambiguous transcription into biochemical 
events
Ambiguous interpretation in biochemical 
terms
Level of description Mechanistic descriptions of processes Mechanistic description of relationships conceptual description of influences
Temporality representation of sequential events Absence of sequentiality between events representation of sequential influences
Pitfalls sensitive to combinatorial explosion of states 
and processes
creation, destruction and translocation are 
not easily represented
Not suitable to represent association, dissocia-
tion, multistate entities
Advantages the best for representing temporal/mechanis-
tic aspects of processes such as metabolism
the best for representing signaling involving 
multistate entities
the best for functional genomics and signaling 
with simple activities
Table 3  List of software systems known to provide support, or to be in the process of developing support, for SBGN
Name Organization Link
Arcadia Manchester centre for Integrative systems Biology, Manchester, UK http://arcadiapathways.sourceforge.net/
Athena University of Washington, seattle, WA, UsA http://www.codeplex.com/athena/
BioModels Database European Bioinformatics Institute, cambridge, UK http://www.ebi.ac.uk/biomodels/
BioUML Institute of systems Biology, Novosibirsk, russia http://www.biouml.org/
ByoDyn Institut Municipal d’Investigació Mèdica, Barcelona, spain http://byodyn.imim.es/
cellDesigner the systems Biology Institute, tokyo http://www.celldesigner.org/
Dunnart Monash University, Melbourne, Australia http://www.csse.monash.edu.au/~mwybrow/dunnart/
Edinburgh Pathway 
Editor
Edinburgh centre for Bioinformatics, Edinburgh, UK http://www.pathwayeditor.org/
JWs Online stellenbosch University, stellenbosch, south Africa http://jjj.biochem.sun.ac.za/
NetBuilder strI, University of Hertfordshire, Hatfield, UK http://strc.herts.ac.uk/bio/maria/Apostrophe/
PANtHEr Artificial Intelligence center, srI international, Menlo Park, cA, UsA http://www.pantherdb.org/pathway/
reactome European Bioinformatics Institute, cambridge, UK http://www.reactome.org/
vanted IPK Gatersleben, Gatersleben, Germany http://vanted.ipk-gatersleben.de/
vIsIOweb Bilkent University, Ankara, turkey http://www.bilkent.edu.tr/~bcbi/pvs.html
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Figure 3  Example of complete sBGN diagrams. (a) Process diagram representing the synthesis of the neurotransmitter acetylcholine in the synaptic button of 
a nerve terminal, its release in the synaptic cleft, degradation in the synaptic cleft, the post-synaptic stimulation of its receptors and the subsequent effect on 
muscle contraction. colors are used to enhance the biological semantics, blue representing catalytic reactions, orange for transport between compartments 
(including unrepresented ions, through channels) and green for the function of contractile proteins. However, it is important to note that those colors are 
not part of sBGN process diagram notation, and must not change the interpretation of the graph. (b) sBGN entity relationship diagram representing the 
transduction, by calcium/calmodulin kinase II, of the effect of voltage-induced increase of intracellular calcium onto the long-term potentiation (LtP) of the 
neuronal synapses, triggered by a translocation of glutamate receptors. the diagram describes the various relationships between the phosphorylations of 
the kinase monomers and their conformation. colors highlight the direction of the relationships relative to the phenotype; blue relationships enhance LtP 
whereas red ones preclude this enhancement. (c) sBGN activity flow diagram representing the cascade of signals triggered by the epidermal growth factor, 
and going from the plasma membrane to the nucleus. the diagram is derived from reference 30.
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Corrigendum: Mass-spectrometric identification and relative quantification 
of N-linked cell surface glycoproteins
Bernd Wollscheid, Damaris Bausch-Fluck, Christine Henderson, Robert O’Brien, Miriam Bibel, Ralph Schiess, Ruedi Aebersold & Julian D Watts
Nat. Biotechnol. 27, 378–386 (2009); published online 5 April 2009; corrected after print 9 September 2009
In the version of this article initially published, in Methods, p. 385, line 5, the concentration of MgCl2, given as 0.5 M, is incorrect. The correct 
concentration is 0.5 mM MgCl2. The error has been corrected in the HTML and PDF versions of the article.
Corrigendum: Multi-site assessment of the precision and reproducibility of 
multiple reaction monitoring–based measurements of proteins in plasma
Terri A Addona, Susan E Abbatiello, Birgit Schilling, Steven J Skates, D R Mani, David M Bunk, Clifford H Spiegelman, Lisa J Zimmerman, 
Amy-Joan L Ham, Hasmik Keshishian, Steven C Hall, Simon Allen, Ronald K Blackman, Christoph H Borchers, Charles Buck,  
Helene L Cardasis, Michael P Cusack, Nathan G Dodder, Bradford W Gibson, Jason M Held, Tara Hiltke, Angela Jackson, Eric B Johansen, 
Christopher R Kinsinger, Jing Li, Mehdi Mesri, Thomas A Neubert, Richard K Niles, Trenton C Pulsipher, David Ransohoff,  
Henry Rodriguez, Paul A Rudnick, Derek Smith, David L Tabb, Tony J Tegeler, Asokan M Variyath, Lorenzo J Vega-Montoto, Åsa Wahlander, 
Sofia Waldemarson, Mu Wang, Jeffrey R Whiteaker, Lei Zhao, N Leigh Anderson, Susan J Fisher, Daniel C Liebler, Amanda G Paulovich,  
Fred E Regnier, Paul Tempst & Steven A Carr
Nat. Biotechnol. 27, 633–641 (2009); published online 28 June 2009; corrected after print 9 September 2009
In the version of this article initially published, the following acknowledgment was inadvertently left out: “The UCSF CPTAC team gratefully 
acknowledges the support of the Canary Foundation for providing funds to purchase a 4000 QTRAP mass spectrometer.” The acknowlegment 
has been added to the HTML and PDF versions of the article.
Erratum: Synergistic drug combinations tend to improve therapeutically 
relevant selectivity
Joseph Lehár, Andrew S Krueger, William Avery, Adrian M Heilbut, Lisa M Johansen, E Roydon Price, Richard J Rickles, Glenn F Short III, 
Jane E Staunton, Xiaowei Jin, Margaret S Lee, Grant R Zimmermann & Alexis A Borisy
Nat. Biotechnol. 7, 659–666 (2009); published online 5 July 2009; corrected after print 8 July 2009
In the version of this article initially published, in the legend of Figure 5b, line 2, “stress” is followed by a period. The period should be a comma, 
so that the sentence reads, “In response to stress, lymphoctyes….” The error has been corrected in the HTML and PDF versions of the article.
Erratum: The Systems Biology Graphical Notation
Nicolas Le Novère, Michael Hucka, Huaiyu Mi, Stuart Moodie, Falk Schreiber, Anatoly Sorokin, Emek Demir, Katja Wegner, Mirit I Aladjem, 
Sarala M Wimalaratne, Frank T Bergman, Ralph Gauges, Peter Ghazal, Hideya Kawaji, Lu Li, Yukiko Matsuoka, Alice Villéger, Sarah E Boyd, 
Laurence Calzone, Melanie Courtot, Ugur Dogrusoz, Tom C Freeman, Akira Funahashi, Samik Ghosh, Akiya Jouraku, Sohyoung Kim,  
Fedor Kolpakov, Augustin Luna, Sven Sahle, Esther Schmidt, Steven Watterson, Guanming Wu, Igor Goryanin, Douglas B Kell, Chris Sander, 
Herbert Sauro, Jacky L Snoep, Kurt Kohn & Hiroaki Kitano
Nat. Biotechnol. 27, 735–741(2009); published online 7 August 2009; corrected after print 11 August 2009
In the version of this article initially published, the wrong versions of Figures 1, 2 and 3 were used. The error has been corrected in the HTML and 
PDF versions of the article.
Erratum: Table of Contents
Nat. Biotechnol. 27, i (2009); published online 7 August 2009; corrected after print 7 August 2009
In the PDF version of the table of contents initially published, a news article titled “Genzyme’s Lumizyme clears bioequivalence hurdles” was omit-
ted. The error has been corrected in the PDF version of the table of contents.
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